13,851 results match your criteria: "Acute Inflammatory Demyelinating Polyradiculoneuropathy"

[Miller-Fisher/Guillain-Barré overlap syndrome following COVID-19 vaccination].

Rev Med Inst Mex Seguro Soc

May 2024

Instituto Mexicano del Seguro Social, Hospital General de Zona No. 1, Servicio de Neurología. Tepic, Nayarit, México.

Background: Anti-GQ1B syndrome includes a group of diseases characterized by antibody-mediated polyneuropathy. Guillain Barre syndrome (GBS) and the Miller-Fisher syndrome (MFS) have been related to COVID-19 vaccine application.

Clinic Case: 48-year-old man, with history of Pfizer-BioNTech vaccination against COVID-19, 5 days prior to the symptoms, who assisted to the Emergency room with blurred vision and diplopia; adding dysarthria, facial diplegia and left upper limb weakness after 48 hours.

View Article and Find Full Text PDF

Introduction: Pfizer-BioNTech (BNT162b2) is one of the mRNA vaccines currently approved by the WHO and the Food and Drug Administration (FDA) against COVID-19.

Case Presentation: Here, the authors report a case of an 8-year-old female with Guillain-Barré syndrome following the second dose of Pfizer-BioNTech (BNT162b2) vaccination requiring respiratory support who was managed with intravenous immunoglobulin.

Discussion: There have been reports of Guillain-Barré syndrome following the Pfizer-BioNTech vaccination.

View Article and Find Full Text PDF

Background: Guillain-Barre syndrome (GBS), an autoimmune disease of the peripheral nervous system, is hallmarked by demyelination and immune cellular infiltration. Experimental autoimmune neuritis (EAN), considered a GBS prototype model, has been studied for its potential therapeutic benefits from lactobacilli. This study evaluated the protective role of Lactobacillus GG (GG) for treatment in EAN.

View Article and Find Full Text PDF

Immune system regulation is a key indicator of the gut microbiota (GM) influencing disease development. The causal role of the GM in Guillain-Barré syndrome (GBS) and whether it can be mediated by immune cells is unknown. Genome-wide association study (GWAS) summary statistics for the GM were obtained from the Dutch Microbiota Project (n = 7,738) and the FINRISK 2002 (FR02) cohort (n = 5,959).

View Article and Find Full Text PDF

Tuberculosis is a global disease and presents with an array of neurological manifestations. Presentation varies from meningitis, radiculo-myelitis, tuberculoma, brain abscess and other combinations. The association of Guillain-Barre' syndrome (GBS) with tuberculosis has been reported in a few reports.

View Article and Find Full Text PDF
Article Synopsis
  • Guillain-Barre Syndrome (GBS) can present with unusual symptoms like paralytic ileus, which is gastrointestinal dysautonomia, before typical motor weakness occurs.
  • A 55-year-old man initially presented with paralytic ileus and subsequently developed severe limb weakness and respiratory failure, despite being treated with supportive therapies.
  • Recognizing early signs of GBS, including gastrointestinal symptoms, is crucial for prompt diagnosis and treatment to minimize severe outcomes and improve patient survival.
View Article and Find Full Text PDF

Unearthing Influenza's Unusual Neurological Impact.

Cureus

November 2024

Acute Medicine, Northern Lincolnshire and Goole NHS Foundation Trust, Scunthorpe, GBR.

Article Synopsis
  • Influenza is a viral infection that mainly targets the respiratory system but can also lead to neurological issues like cognitive impairment and seizures.
  • A case study involving a middle-aged male showed flu-like symptoms followed by peripheral neuropathy, with extensive tests revealing no other causes except for Influenza A.
  • The patient responded well to conservative treatment, suggesting that his neuropathy was likely caused by the influenza infection.
View Article and Find Full Text PDF

Background: Miller fisher syndrome (MFS) is a variant of Guillain-Barré syndrome, an acute immune-mediated peripheral neuropathy that is often secondary to viral infections. Anti-ganglioside antibodies play crucial roles in the development of MFS. The positive rate of ganglioside antibodies is exceptionally high in MFS patients, particularly for anti-GQ1b antibodies.

View Article and Find Full Text PDF

Zika virus has raised global concerns due to its link to microcephaly and Guillain-Barré syndrome in adults. One of viral nonstructural proteins-NS4B, an integral membrane protein, plays crucial roles in viral replication by interacting with both viral and host proteins, rendering it an attractive drug target for antiviral development. We purified the N-terminal region of ZIKV NS4B (NS4B NTD) and reconstituted it into detergent micelles.

View Article and Find Full Text PDF

Clinical characteristics and functional outcomes of pediatric Guillain-Barré syndrome admitted to the Neuro-intensive care unit: a decade-long retrospective observational study.

Neurol Sci

November 2024

Department of Neuroanaesthesia and Neurocritical Care, National Institute of Mental Health and Neuro Sciences (NIMHANS), Neurocentre Faculty Block, 3rd Floor, Hosur road, Bengaluru, Karnataka, 560029, India.

Background: Guillain-Barré Syndrome (GBS) remains a significant contributor to acute flaccid paralysis in pediatric patients worldwide. Despite its impact, studies focusing on pediatric GBS requiring intensive care unit (ICU) management are limited. This study aimed to address this gap by exploring the clinical and outcome characteristics of pediatric GBS necessitating ICU care.

View Article and Find Full Text PDF
Article Synopsis
  • Therapeutic plasma exchange is an established treatment that improves neurological symptoms by removing antibodies in patients with autoimmune neurological diseases, as shown through an 11-year study.
  • The study reviewed data from 265 patients who underwent 1,274 plasma exchange procedures, mostly for conditions like Guillain-Barré syndrome and myasthenia gravis, revealing an overall response rate of 81.3%.
  • The treatment was considered safe, with only minor complications like manageable allergic reactions and one serious case of hypertensive crisis, indicating a favorable side effect profile.
View Article and Find Full Text PDF

Diagnostic criteria and therapeutic implications of rapid-onset demyelinating polyneuropathies.

Exp Mol Pathol

December 2024

Clinical Department of Neurology, University Centre of Neurology and Neurosurgery, Faculty of Medicine, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland. Electronic address:

Guillain-Barré syndrome (GBS) and acute-onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) are the most common autoimmune polyneuropathies. Their aetiology is unclear. The pathomechanism includes damage mainly to the myelin sheath and, in the long-term process, secondary axonal loss.

View Article and Find Full Text PDF

This case report presents a rare instance of acute motor axonal neuropathy (AMAN), a subtype of Guillain-Barré syndrome (GBS), in a 25-year-old postpartum female. The patient experienced a seven-day history of progressive, ascending motor weakness in all four limbs, beginning shortly before delivery and rapidly worsening postpartum. Notably, she exhibited no sensory deficits, a hallmark feature of AMAN, which was confirmed by nerve conduction studies revealing significant motor axonal involvement with preserved sensory function.

View Article and Find Full Text PDF

Zika virus (ZIKV) is a mostly non-lethal disease in humans transmitted by mosquitoes or humans that can produce severe brain defects such as microcephaly in babies and Guillain-Barré syndrome in elderly adults. The use of optimal control strategies involving information campaigns about insect repellents and condoms alongside an available safe and effective vaccine can prevent the number of infected humans with ZIKV. A system of nonlinear ordinary differential equations is formulated for the transmission dynamics of ZIKV in the presence of three control strategies to evaluate the impact of various scenarios during a ZIKV epidemic.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers analyzed data from Iranian hospitals, finding a total of 1,282 registered GBS cases (778 pre-COVID vs. 504 during COVID), indicating a decrease in diagnoses during the pandemic.
  • * The study concluded that while GBS cases dropped during COVID-19, there were no significant changes in demographic characteristics, clinical outcomes, or mortality rates between the two periods.
View Article and Find Full Text PDF
Article Synopsis
  • The study focused on diagnosing Acute Flaccid Paralysis (AFP) in children referred to a pediatric emergency unit between 2011 and 2016.
  • The most common diagnoses were Guillain-Barré Syndrome (80 cases), acute viral myositis (20 cases), Transverse Myelitis Syndrome (6 cases), and Vaccine-Associated Paralytic Poliomyelitis (6 cases), with all patients testing negative for poliovirus.
  • A unique case of a 2.5-month-old patient presented with symptoms compatible with viral meningitis, highlighting the importance of considering a range of diagnoses when evaluating AFP in children.
View Article and Find Full Text PDF

Objectives: Neurological manifestations of Severe Acute Respiratory Syndrome coronavirus-2 have been well documented in adults during and after infection with the virus as well as after vaccination. The incidence of severe neurological symptoms among children is very low. This study aimed to analyze the varied neurological manifestations after COVID-19 infection among children and give a report on a single-center experience with these severe neurological symptoms.

View Article and Find Full Text PDF

Background: Neuropathic tremor occurs with damage to the peripheral nervous system. Guillain-Barré syndrome (GBS) causes acute paralysis following nerve inflammation sometimes resulting in long-term disability. It is unclear how frequent and severe tremor is following GBS.

View Article and Find Full Text PDF
Article Synopsis
  • The Zika virus (ZIKV), an arbovirus from the Flavivirus genus, was first discovered in a monkey in Uganda in 1947 and has seen increasing prevalence, especially during a significant outbreak in the US in 2015 that caused severe health issues.
  • Symptoms include organ failure, microcephaly, and Guillain-Barré syndrome, with the virus primarily transmitted through Aedes mosquitoes, but can also spread via blood, sexual contact, and from mothers to their babies.
  • There's currently no specific treatment or vaccine for ZIKV, leading researchers to investigate its pathogenesis and clinical symptoms to improve understanding and develop future prevention and treatment strategies.
View Article and Find Full Text PDF

Relationship between Guillain-Barré syndrome and Cardiovascular disease: A bidirectional Mendelian randomization study.

Physiol Genomics

October 2024

Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing,, Beijing, --- Select One ---, China.

Background And Objective: Guillain-Barré syndrome (GBS) and cardiovascular diseases (CVDs) have been observed to have a potential association, with GBS potentially leading to cardiovascular complications. However, these observational studies may be influenced by confounding factors. This study aimed to assess the causal relationship between GBS and CVDs, including heart failure (HF), atrial fibrillation (AF), and coronary artery disease (CAD), using a two-sample bidirectional Mendelian randomization (MR) analysis.

View Article and Find Full Text PDF
Article Synopsis
  • Monoclonal antibodies (mAbs) like daratumumab and elotuzumab have greatly improved treatment for multiple myeloma (MM), but their neuropsychiatric safety lacks sufficient post-marketing data.
  • This study utilized the FDA Adverse Events Reporting System (FAERS) database to analyze neuropsychiatric adverse events (AEs) linked to mAbs for MM from 2015 to 2023.
  • The analysis uncovered significant signals of disproportionate reporting (SDRs) for various neuropsychiatric issues associated with these drugs, indicating a need for further research into their safety profiles, particularly for conditions like Guillain-Barre syndrome (GBS).
View Article and Find Full Text PDF

The Ambivalence of Post COVID-19 Vaccination Responses in Humans.

Biomolecules

October 2024

Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.

Article Synopsis
  • The COVID-19 pandemic, caused by SARS-CoV-2, led to a swift global vaccination effort, resulting in the development and emergency use of multiple vaccine types, including mRNA and adenovirus-based options.
  • The vaccines primarily aim to prevent severe illness and death from COVID-19, administered in multiple doses, but they can cause common mild to moderate side effects and some rare serious reactions.
  • Ongoing research is essential to assess these side effects better, yet the overall safety profile of the vaccines supports their use in fighting the pandemic, highlighting vaccination's critical role in reducing severe COVID-19 outcomes.
View Article and Find Full Text PDF